We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NTRA market cap is 12.61B. The company's latest EPS is USD -3.5406 and P/E is -28.98.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 241.76M | 261.4M | 268.31M | 311.11M | 367.74M |
Operating Income | -138.3M | -112.43M | -110.98M | -84.54M | -74.31M |
Net Income | -136.94M | -111.05M | -108.79M | -78.03M | -67.6M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 316.72M | 391.01M | 625.49M | 820.22M | 1.08B |
Operating Income | -116.29M | -216.28M | -468.17M | -541.04M | -446.25M |
Net Income | -124.83M | -229.74M | -471.72M | -547.8M | -434.8M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.32B | 1.25B | 1.45B | 1.44B | 1.47B |
Total Liabilities | 668.31M | 651.75M | 661.86M | 676.37M | 674.09M |
Total Equity | 650.57M | 596.15M | 784.66M | 765.33M | 794.11M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 582.66M | 932.15M | 1.24B | 1.39B | 1.44B |
Total Liabilities | 303.95M | 445.92M | 583.18M | 688.73M | 676.37M |
Total Equity | 278.71M | 486.24M | 653.3M | 705.74M | 765.33M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -80.89M | -159.28M | -188.83M | -246.96M | 27M |
Investing | 15.65M | 62.68M | 143.83M | 168.5M | 138.26M |
Financing | 2.3M | 11.61M | 247.62M | 254.46M | 6.47M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -63.44M | -182.51M | -335.24M | -431.5M | -246.96M |
Investing | -266.35M | -331.46M | -205.19M | 330.34M | 168.5M |
Financing | 340.77M | 500.85M | 576.19M | 482.64M | 254.46M |
Market Cap | 12.61B |
Price to Earnings Ratio | -28.98 |
Price to Sales Ratio | 11.64 |
Price to Cash Ratio | 19.63 |
Price to Book Ratio | 16.47 |
Dividend Yield | - |
Shares Outstanding | 122.8M |
Average Volume (1 week) | 1.61M |
Average Volume (1 Month) | 1.32M |
52 Week Change | 119.29% |
52 Week High | 117.23 |
52 Week Low | 36.90 |
Spread (Intraday) | 7.65 (7.08%) |
Company Name | Natera Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.natera.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions